Hedge Fund - Vivo Capital
Verona Pharma Plc (VRNA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $91,348,460 | 12.1% | 1,438,785 | $59.82 |
| 2 | 2024 - Q4 (2024-12-31) | $106,067,799 | 11.88% | 2,283,975 | $37.54 |
| 3 | 2024 - Q3 (2024-09-30) | $102,126,538 | 8.45% | 3,549,758 | $24.61 |
| 4 | 2024 - Q2 (2024-06-30) | $51,329,501 | 4.74% | 3,549,758 | $14.60 |
| 5 | 2024 - Q1 (2024-03-31) | $58,087,748 | 4.56% | 3,610,177 | $17.29 |
| 6 | 2023 - Q4 (2023-12-31) | $84,488,370 | 6.91% | 4,249,918 | $14.77 |
| 7 | 2023 - Q3 (2023-09-30) | $69,273,663 | 7.58% | 4,249,918 | $19.26 |
| 8 | 2023 - Q2 (2023-06-30) | $89,843,267 | 6.2% | 4,249,918 | $21.33 |
| 9 | 2023 - Q1 (2023-03-31) | $85,338,353 | 5.92% | 4,249,918 | $21.59 |
| 10 | 2022 - Q4 (2022-12-31) | $3,637 | 0.41% | 4,249,918 | $13.32 |
| 11 | 2022 - Q3 (2022-09-30) | $43,434,000 | 4.79% | 4,249,918 | $8.43 |
| 12 | 2022 - Q2 (2022-06-30) | $11,522,000 | 1.15% | 2,749,918 | $4.28 |
| 13 | 2022 - Q1 (2022-03-31) | $13,722,000 | 0.94% | 2,749,918 | $5.82 |
| 14 | 2021 - Q4 (2021-12-31) | $18,479,000 | 1.11% | 2,749,918 | $5.11 |
| 15 | 2021 - Q3 (2021-09-30) | $15,070,000 | 0.67% | 2,749,918 | $5.82 |
| 16 | 2021 - Q2 (2021-06-30) | $19,937,000 | 0.86% | 3,048,507 | $6.93 |
| 17 | 2021 - Q1 (2021-03-31) | $25,486,000 | 0.89% | 3,048,507 | $8.30 |
| 18 | 2020 - Q4 (2020-12-31) | $21,340,000 | 0.95% | 3,048,507 | $6.75 |
| 19 | 2020 - Q3 (2020-09-30) | $19,023,000 | 1.09% | 3,048,507 | $6.91 |
| 20 | 2020 - Q2 (2020-06-30) | $6,987,000 | 0.5% | 1,492,951 | $4.63 |
| 21 | 2020 - Q1 (2020-03-31) | $6,151,000 | 0.55% | 1,492,951 | $5.49 |
| 22 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $4.49 |
| 23 | 2019 - Q2 (2019-06-30) | $7,614,000 | 0.71% | 1,492,951 | $6.10 |
| 24 | 2019 - Q1 (2019-03-31) | $9,704,000 | 0.96% | 1,492,951 | $6.57 |
| 25 | 2018 - Q4 (2018-12-31) | $13,437,000 | 1.71% | 1,492,951 | $11.33 |
| 26 | 2018 - Q3 (2018-09-30) | $18,677,000 | 1.88% | 1,492,951 | $12.95 |
| 27 | 2018 - Q2 (2018-06-30) | $2,792,000 | 0.35% | 1,492,951 | $16.81 |
| 28 | 2018 - Q1 (2018-03-31) | $29,859,000 | 4.22% | 1,492,951 | $14.17 |
| 29 | 2017 - Q4 (2017-12-31) | $17,723,000 | 3.79% | 1,492,951 | $12.95 |
| 30 | 2017 - Q3 (2017-09-30) | $22,917,000 | 4.63% | 1,492,951 | $13.09 |
| 31 | 2017 - Q2 (2017-06-30) | $8,208,000 | 2.06% | 704,225 | $13.24 |
The displayed share prices are average quarterly stock market prices.